Personal information

Other IDs

Scopus Author ID: 56717762600
SciProfiles: 829964

Keywords

cancer: signaling and therapy, cell biology and biochemistry, oxidative stress

Countries

Iran

Activities

Collapse all

Employment (1)

Kurdistan University of Medical Sciences: Sanandaj, IR

Employment
Source: Self-asserted source
Keywan Mortezaee

Education and qualifications (1)

Kurdistan University of Medical Sciences: Sanandaj, IR

2012-02-01 to 2015-05-11 | PHD (Anatomy)
Education
Source: Self-asserted source
Keywan Mortezaee

Works (50 of 67)

Items per page:
Page 1 of 2

An Update of Extracellular Vesicle Involvement in Different Steps of Cancer Metastasis and Targeting Strategies

Current Medicinal Chemistry
2024-08 | Journal article
DOI: 10.2174/0109298673273299231121044055
Contributors: Keywan Mortezaee; Jamal Majidpoor
Source: check_circle
Crossref

FOXP3 (in)stability and cancer immunotherapy

Cytokine
2024-06 | Journal article
DOI: 10.1016/j.cyto.2024.156589
Contributors: Keywan Mortezaee
Source: check_circle
Crossref

Selective targeting or reprogramming of intra-tumoral Tregs

Medical Oncology
2024-02-11 | Journal article
DOI: 10.1007/s12032-024-02300-0
Contributors: Keywan Mortezaee
Source: check_circle
Crossref

Alternative immune checkpoints in immunoregulatory profile of cancer stem cells

Heliyon
2023-12 | Journal article
DOI: 10.1016/j.heliyon.2023.e23171
Contributors: Keywan Mortezaee; Jamal Majidpoor
Source: check_circle
Crossref

Extracellular vesicle–based drug delivery in cancer immunotherapy

Drug Delivery and Translational Research
2023-11 | Journal article
DOI: 10.1007/s13346-023-01370-3
Contributors: Sajad Najafi; Jamal Majidpoor; Keywan Mortezaee
Source: check_circle
Crossref

Strategies for Application of Extracellular Vesicles in Solid Cancer Therapy

Scientific Journal of Kurdistan University of Medical Sciences
2023-10-01 | Journal article
DOI: 10.61186/sjku.28.4.160
Contributors: jamal majidpoor; fardin fathi; Keywan Mortezaee
Source: check_circle
Crossref

Dual anti-PD-(L)1/TGF-β inhibitors in cancer immunotherapy – Updated

International Immunopharmacology
2023-09 | Journal article
DOI: 10.1016/j.intimp.2023.110648
Contributors: Zana Karami; Keywan Mortezaee; Jamal Majidpoor
Source: check_circle
Crossref

Advances in dendritic cell vaccination therapy of cancer

Biomedicine & Pharmacotherapy
2023-08 | Journal article
DOI: 10.1016/j.biopha.2023.114954
Contributors: Sajad Najafi; Keywan Mortezaee
Source: check_circle
Crossref

The impact of PD-L1 as a biomarker of cancer responses to combo anti-PD-1/CTLA-4

Pathology - Research and Practice
2023-07 | Journal article
DOI: 10.1016/j.prp.2023.154583
Contributors: Sasan Parvini; Jamal Majidpoor; Keywan Mortezaee
Source: check_circle
Crossref

Dysregulated metabolism: A friend-to-foe skewer of macrophages

International Reviews of Immunology
2023-07-04 | Journal article
DOI: 10.1080/08830185.2022.2095374
Contributors: Keywan Mortezaee; Jamal Majidpoor
Source: check_circle
Crossref

B7x in cancer immunity and immunotherapy

International Immunopharmacology
2023-05 | Journal article
DOI: 10.1016/j.intimp.2023.110133
Contributors: Keywan Mortezaee
Source: check_circle
Crossref

Indoleamine 2,3-dioxygenase 1 in circumventing checkpoint inhibitor responses: Updated

International Immunopharmacology
2023-05 | Journal article
DOI: 10.1016/j.intimp.2023.110032
Contributors: Arian Charehjoo; Jamal Majidpoor; Keywan Mortezaee
Source: check_circle
Crossref

Anti-PD-(L)1 therapy of non-small cell lung cancer–A summary of clinical trials and current progresses

Heliyon
2023-03 | Journal article
DOI: 10.1016/j.heliyon.2023.e14566
Contributors: Keywan Mortezaee; Jamal Majidpoor
Source: check_circle
Crossref

The impact of hypoxia on extracellular vesicle secretome profile of cancer

Medical Oncology
2023-03-24 | Journal article
DOI: 10.1007/s12032-023-01995-x
Contributors: Keywan Mortezaee; Jamal Majidpoor
Source: check_circle
Crossref

Transforming growth factor‐β signalling in tumour resistance to the anti‐PD‐(L)1 therapy: Updated

Journal of Cellular and Molecular Medicine
2023-02 | Journal article
DOI: 10.1111/jcmm.17666
Contributors: Keywan Mortezaee; Jamal Majidpoor
Source: check_circle
Crossref

Extracellular vesicle isolation, purification and evaluation in cancer diagnosis

Expert Reviews in Molecular Medicine
2022 | Journal article
DOI: 10.1017/erm.2022.34
Contributors: Keywan Mortezaee; Jamal Majidpoor; Fardin Fathi
Source: check_circle
Crossref

Extracellular vesicle-based checkpoint regulation and immune state in cancer

Medical Oncology
2022-09-29 | Journal article
DOI: 10.1007/s12032-022-01837-2
Contributors: Keywan Mortezaee; Jamal Majidpoor
Source: check_circle
Crossref

Epithelial-mesenchymal transition in cancer stemness and heterogeneity: updated

Medical Oncology
2022-09-07 | Journal article
DOI: 10.1007/s12032-022-01801-0
Contributors: Keywan Mortezaee; Jamal Majidpoor; Ebrahim Kharazinejad
Source: check_circle
Crossref

Checkpoint inhibitor/interleukin‐based combination therapy of cancer

Cancer Medicine
2022-08 | Journal article
DOI: 10.1002/cam4.4659
Contributors: Keywan Mortezaee; Jamal Majidpoor
Source: check_circle
Crossref

Roles for macrophage-polarizing interleukins in cancer immunity and immunotherapy

Cellular Oncology
2022-06 | Journal article
DOI: 10.1007/s13402-022-00667-8
Contributors: Keywan Mortezaee; Jamal Majidpoor
Source: check_circle
Crossref

NK and cells with NK-like activities in cancer immunotherapy-clinical perspectives

Medical Oncology
2022-06-18 | Journal article
DOI: 10.1007/s12032-022-01735-7
Contributors: Keywan Mortezaee; Jamal Majidpoor
Source: check_circle
Crossref

Key promoters of tumor hallmarks

International Journal of Clinical Oncology
2022-01 | Journal article
DOI: 10.1007/s10147-021-02074-9
Contributors: Keywan Mortezaee; Jamal Majidpoor
Source: check_circle
Crossref

The current knowledge concerning solid cancer and therapy

Journal of Biochemical and Molecular Toxicology
2021-11 | Journal article
DOI: 10.1002/jbt.22900
Contributors: Masoud Najafi; Jamal Majidpoor; Heidar Toolee; Keywan Mortezaee
Source: check_circle
Crossref

Normalization in tumor ecosystem: Opportunities and challenges

Cell Biology International
2021-10 | Journal article
DOI: 10.1002/cbin.11655
Contributors: Keywan Mortezaee
Source: check_circle
Crossref

Interleukin-2 therapy of cancer-clinical perspectives

International Immunopharmacology
2021-09 | Journal article
DOI: 10.1016/j.intimp.2021.107836
Contributors: Jamal Majidpoor; Keywan Mortezaee
Source: check_circle
Crossref

Angiogenesis as a hallmark of solid tumors - clinical perspectives

Cellular Oncology
2021-08 | Journal article
DOI: 10.1007/s13402-021-00602-3
Contributors: Jamal Majidpoor; Keywan Mortezaee
Source: check_circle
Crossref

Organ Tropism in Solid Tumor Metastasis: An Updated Review

Future Oncology
2021-05 | Journal article
DOI: 10.2217/fon-2020-1103
Contributors: Keywan Mortezaee
Source: check_circle
Crossref

Enriched cancer stem cells, dense stroma, and cold immunity: Interrelated events in pancreatic cancer

Journal of Biochemical and Molecular Toxicology
2021-04 | Journal article
DOI: 10.1002/jbt.22708
Contributors: Keywan Mortezaee
Source: check_circle
Crossref

The effect of the “segment” of spinal cord injury on the activity of the nucleotide‐binding domain‐like receptor protein 3 inflammasome and response to hormonal therapy

Cell Biochemistry and Function
2021-03 | Journal article
DOI: 10.1002/cbf.3574
Contributors: Jamal Majidpoor; Keywan Mortezaee; Zahra Khezri; Fardin Fathi; Alireza Zali; Homayoon Bana Derakhshan; Mehdi Ghasemzadeh Bariki; Mohammad Taghi Joghataie; Reza Shirazi; Fatemeh Moradi
Source: check_circle
Crossref

Redox tolerance and metabolic reprogramming in solid tumors

Cell Biology International
2021-02 | Journal article
DOI: 10.1002/cbin.11506
Contributors: Keywan Mortezaee
Source: check_circle
Crossref

Steps in metastasis: an updated review

Medical Oncology
2021-01 | Journal article
DOI: 10.1007/s12032-020-01447-w
Contributors: Jamal Majidpoor; Keywan Mortezaee
Source: check_circle
Crossref

The expressions of NLRP1, NLRP3, and AIM2 inflammasome complexes in the contusive spinal cord injury rat model and their responses to hormonal therapy

Cell and Tissue Research
2020-09-21 | Journal article
DOI: 10.1007/s00441-020-03250-5
Contributors: Jamal Majidpoor; Zahra Khezri; Parsa Rostamzadeh; Keywan Mortezaee; Mohammad Jafar Rezaie; Fardin Fathi; Morteza Abouzaripour; Mehdi Ghasemzadeh Bariki; Fatemeh Moradi; Reza Shirazi et al.
Source: check_circle
Crossref

Effects of neural stem cell‐derived extracellular vesicles on neuronal protection and functional recovery in the rat model of middle cerebral artery occlusion

Cell Biochemistry and Function
2020-06 | Journal article
DOI: 10.1002/cbf.3484
Contributors: Marzieh Mahdavipour; Gholamreza Hassanzadeh; Elham Seifali; Keywan Mortezaee; Hadi Aligholi; Faezeh Shekari; Parisa Sarkoohi; Zahra Zeraatpisheh; Abdoreza Nazari; Shabnam Movassaghi et al.
Source: check_circle
Crossref

Intranasal delivery of SDF‐1α‐preconditioned bone marrow mesenchymal cells improves remyelination in the cuprizone‐induced mouse model of multiple sclerosis

Cell Biology International
2020-02 | Journal article
DOI: 10.1002/cbin.11250
Contributors: Fatemeh Beigi Boroujeni; Parichehr Pasbakhsh; Keywan Mortezaee; Vahid Pirhajati; Rafieh Alizadeh; Roya Aryanpour; Soheila Madadi; Iraj Ragerdi Kashani
Source: check_circle
Crossref

Resveratrol as an Adjuvant for Normal Tissues Protection and Tumor Sensitization

Current Cancer Drug Targets
2020-02-11 | Journal article
DOI: 10.2174/1568009619666191019143539
Contributors: Keywan Mortezaee; Masoud Najafi; Bagher Farhood; Amirhossein Ahmadi; Dheyauldeen Shabeeb; Ahmed E. Musa
Source: check_circle
Crossref

Hypoxia in solid tumors: a key promoter of cancer stem cell (CSC) resistance

Journal of Cancer Research and Clinical Oncology
2020-01 | Journal article
DOI: 10.1007/s00432-019-03080-1
Contributors: Masoud Najafi; Bagher Farhood; Keywan Mortezaee; Ebrahim Kharazinejad; Jamal Majidpoor; Reza Ahadi
Source: check_circle
Crossref

Stromal reprogramming: A target for tumor therapy

Life Sciences
2019-12 | Journal article
DOI: 10.1016/j.lfs.2019.117049
Contributors: Masoud Najafi; Keywan Mortezaee; Jamal Majidpoor
Source: check_circle
Crossref

Extracellular‐signal‐regulated kinase/mitogen‐activated protein kinase signaling as a target for cancer therapy: an updated review

Cell Biology International
2019-11 | Journal article
DOI: 10.1002/cbin.11187
Contributors: Masoud Najafi; Amirhossein Ahmadi; Keywan Mortezaee
Source: check_circle
Crossref

Selenium as an adjuvant for modification of radiation response

Journal of Cellular Biochemistry
2019-11 | Journal article
DOI: 10.1002/jcb.29171
Contributors: Bagher Farhood; Keywan Mortezaee; Elahe Motevaseli; Hanifeh Mirtavoos‐Mahyari; Dheyauldeen Shabeeb; Ahmed Eleojo Musa; Nafiseh Sadat Sanikhani; Masoud Najafi; Amirhossein Ahmadi
Source: check_circle
Crossref

Cancer stem cell (CSC) resistance drivers

Life Sciences
2019-10 | Journal article
DOI: 10.1016/j.lfs.2019.116781
Contributors: Masoud Najafi; Keywan Mortezaee; Jamal Majidpoor
Source: check_circle
Crossref

Genomic Instability and Carcinogenesis of Heavy Charged Particles Radiation: Clinical and Environmental Implications

Medicina
2019-09-13 | Journal article
DOI: 10.3390/medicina55090591
Contributors: Keywan Mortezaee; Masoud Najafi; Bagher Farhood; Amirhossein Ahmadi; Dheyauldeen Shabeeb; Ahmed Eleojo Musa
Source: check_circle
Crossref

Cancer stem cell (a)symmetry & plasticity: Tumorigenesis and therapy relevance

Life Sciences
2019-08 | Journal article
DOI: 10.1016/j.lfs.2019.05.076
Contributors: Masoud Najafi; Keywan Mortezaee; Reza Ahadi
Source: check_circle
Crossref

Transforming growth factor‐β signaling: Tumorigenesis and targeting for cancer therapy

Journal of Cellular Physiology
2019-08 | Journal article
DOI: 10.1002/jcp.27955
Contributors: Amirhossein Ahmadi; Masoud Najafi; Bagher Farhood; Keywan Mortezaee
Source: check_circle
Crossref

Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review

Life Sciences
2019-07 | Journal article
DOI: 10.1016/j.lfs.2019.05.009
Contributors: Keywan Mortezaee; Masoud Najafi; Bagher Farhood; Amirhossein Ahmadi; Yaiza Potes; Dheyauldeen Shabeeb; Ahmed Eleojo Musa
Source: check_circle
Crossref

Cancer stem cells (CSCs) in cancer progression and therapy

Journal of Cellular Physiology
2019-06 | Journal article
DOI: 10.1002/jcp.27740
Contributors: Masoud Najafi; Bagher Farhood; Keywan Mortezaee
Source: check_circle
Crossref

CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review

Journal of Cellular Physiology
2019-06 | Journal article
DOI: 10.1002/jcp.27782
Contributors: Bagher Farhood; Masoud Najafi; Keywan Mortezaee
Source: check_circle
Crossref

Contribution of regulatory T cells to cancer: A review

Journal of Cellular Physiology
2019-06 | Journal article
DOI: 10.1002/jcp.27553
Contributors: Masoud Najafi; Bagher Farhood; Keywan Mortezaee
Source: check_circle
Crossref

Effect of the CSF1R inhibitor PLX3397 on remyelination of corpus callosum in a cuprizone‐induced demyelination mouse model

Journal of Cellular Biochemistry
2019-06 | Journal article
DOI: 10.1002/jcb.28344
Contributors: Fatemeh Tahmasebi; Parichehr Pasbakhsh; Keywan Mortezaee; Soheila Madadi; Shirin Barati; Iraj Ragerdi Kashani
Source: check_circle
Crossref

Oncolytic adenovirus: A tool for cancer therapy in combination with other therapeutic approaches

Journal of Cellular Physiology
2019-06 | Journal article
DOI: 10.1002/jcp.27850
Contributors: Nasser Hashemi Goradel; Nasir Mohajel; Ziba Veisi Malekshahi; Samira Jahangiri; Masoud Najafi; Bagher Farhood; Keywan Mortezaee; Babak Negahdari; Arash Arashkia
Source: check_circle
Crossref

Cyclooxygenase‐2 in cancer: A review

Journal of Cellular Physiology
2019-05 | Journal article
DOI: 10.1002/jcp.27411
Contributors: Nasser Hashemi Goradel; Masoud Najafi; Eniseh Salehi; Bagher Farhood; Keywan Mortezaee
Source: check_circle
Crossref
Items per page:
Page 1 of 2
How many people are using ORCID?